Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy - Concepedia

Concepedia

Publication | Open Access

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy

DOI Full Paper Access

105

Citations

43

References

2017

Year

Antonino Musolino, Mario Campone, Patrick Neven, Neelima Denduluri, Carlos H. Barrios, Javier Cortés, Kimberly Blackwell, Hatem Soliman, Zsuzsanna Kahán, Hervé Bonnefoi,

Breast Cancer Research

Abstract

ClinicalTrials.gov identifier: NCT01528345 . Registered 31 January 2012.

References

	Year	Citations

Page 1